Ventyx Biosciences Inc
VTYX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1B
Close$
$0.24
98.3% downside
Current Fair Value
98.3% downsideOvervalued by 98.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.00 Billion |
|---|---|
| Enterprise Value | $982.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.97 |
| Beta | 1.27 |
| Outstanding Shares | 71,304,084 |
Return
| Return on Equity | -55.71% |
|---|---|
| Return on Assets | -50.41% |
| Return on Invested Capital | -58.46% |
Valuation & Multiples
| P/E Ratio | -9.36 |
|---|---|
| PEG | 26.58 |
| Price to Sales | - |
| Price to Book Ratio | 7.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8.39 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 5, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 5.3965▲ 510.76% |
|---|---|
| Total Calls | 483,500▲ 218.93% |
| Total Puts | 2,609,200▲ 5857.08% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 73.24%▲ 11.65% |
|---|---|
| Total Invested | $471.59M▲ 245.79% |
| Investors Holding | 152▲ 37.00% |
ESG Score
No data